Huaihua Baohua Biotechnology Co.,Ltd is a science-technology enterprise integrated with development, production and sales. We are good at various reaction types including Cyanation、Hydrogenation reduction、Grignard、Alkylation,etc. Company characteristics: 1.producing middle-high-end intermediates of pharmaceutical & electronic chemicals. 2.Custom synthesis: manufacturing various kinds of chemicals according to customer’s requirements,flexible small and pilot production platform. 3.Professional QA &QC team,good quality management system.Coerring QA,QC and production departments,leding the development of the enterprise in future. Typical projects: Bicalutamide intermediates/Scarpogrelate intermediates/Tapentadol intermediates/Cinacalcet intermediates/Zafirlukast intermediates/Olopatadine intermediates
Year Established: 2003
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 10-50
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Business Type: Manufacturer
R&D Capacity: Own Brand
Annual Turnover(USD) : 500,000 to 99,999,999
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Asia,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
(3-carboxypropyl)trimethylammonium chloride
Pyridoxal phosphate
2-methyl-2-pentenoic acid
(S)-(-)-Indoline-2-carboxylic acid